About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Resistant Arterial Hypertension Cohort Study | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT01083017

Resistant Arterial Hypertension Cohort Study

The purpose of this study is to investigate the epidemiology of resistant hypertension, evaluate the efficacy and feasibility of a standardized drug treatment regimen (including the randomization of t...

Lead sponsor: University Hospital, Geneva•3 locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University Hospital, Geneva

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•informed consent
•resistant hypertension at the moment of inclusion
•18 years or more, both sexes are included
•women at reproductive age: consenting to use oral contraception

Exclusion Criteria

•patients mentally impaired or unable to give informed consent
•patients speaking only a foreign language other than French, German, or English
•patients living far away, making the study visits not practical

Related studies

RECRUITINGPhase 3

A Study to Evaluate the Efficacy and Safety of Once Daily Treprostinil Palmitil Inhalation Powder (TPIP) in Participants With Pulmonary Arterial Hypertension (PAH)

NCT07481981 · Pulmonary Arterial Hypertension

Mitigation of Health Effects in Older Adults With Hypertension by Reducing Exposure to Heat and Air Pollution

NCT07606859 · Hypertension Arterial, 65 Years Older

RECRUITINGPhase 4

Treatment With Aspirin After Preeclampsia: TAP Trial

NCT06281665 · Hypertensive Disorder of Pregnancy, Pre-Eclampsia, and more

Regional Innovation in Chronic Disease and Elderly Care

NCT07578090 · Hypertension, Cardiovascular Disease, and more

Microplastics, Cirrhosis and Portal Hypertension

NCT07280390 · Cirrhosis, Microplastics, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: October 30, 2018Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment74

Start dateApr 2011

Last updatedOct 30, 2018

Condition

Hypertension Essential Hypertension Resistant Hypertension

Locations shown

Geneva University Hospitals

Geneva

Lausanne University Hospital, CHUV

Lausanne

Kantonsspital Luzern

Lucerne

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: October 30, 2018Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions